Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...

1 School of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, China 2 School of Bioengineering, Qilu University of Technology, Shandong Academy of Science, Jinan, ...

Herpes zoster (HZ) is common in older people, with a lifetime risk of 25%. The main risk factors are advanced age and immunosuppression. People with a rheumatic and musculoskeletal disease have an ...

JUNCTION CITY, Kan.--(BUSINESS WIRE)--InVitria, a leading developer of recombinant, chemically defined components for biomanufacturing, has announced the launch of Optibumin® 25, the first and only ...

Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China The modified vaccinia virus Ankara (MVA) is approved for use as a smallpox and monkeypox virus vaccine and was ...

- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...

Citing cost increases and fraud in the program, state Sen. George Borrello and several members of the Senate Republican Conference call on Gov. Kathy ...

- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing ...

Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access ...